HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousSexual BehaviorRisk FactorsSeroepidemiologic StudiesProspective StudiesRetrospective StudiesAntibodies, ViralPrevalenceAntibodies, BacterialChlamydophila pneumoniaeTreatment OutcomeFollow-Up StudiesChlamydophila InfectionsImmunoglobulin GTime FactorsCross-Sectional StudiesSerologic TestsCase-Control StudiesEnzyme-Linked Immunosorbent AssayHIV SeronegativityCohort StudiesSaudi ArabiaHelicobacter pyloriHelicobacter InfectionsRenal DialysisAge FactorsIncidenceToxocariasisLogistic ModelsMultivariate AnalysisAntibodies, ProtozoanCytomegalovirus InfectionsChi-Square DistributionOdds RatioKidney Failure, ChronicSeverity of Illness IndexToxoplasmosisAcquired Immunodeficiency SyndromeUnited StatesToxocaraPrognosisHerpesvirus 2, HumanAIDS SerodiagnosisHIV-1IranPredictive Value of TestsBlood DonorsSurvival RateQuestionnairesHepatitis CRisk AssessmentSensitivity and SpecificityNeosporaKidney TransplantationPapillomavirus InfectionsRural PopulationBiological MarkersSyphilisHerpes GenitalisCytomegalovirusToxoplasmaImmunoglobulin ABrazilComorbidityHomosexualitySurvival AnalysisSex Factors